Over the last 15 years, many studies have established an association of sleep apnea with inflammation and metabolic aberrations. However, no controlled studies have examined potential gender effects in this association. We recruited 120 middle-aged, predominantly non-obese mild-to-moderate sleep apneics and controls (62 males, 58 females). All participants underwent a clinical history, physical examination, and 1-night 8-h polysomnography recording and provided a single fasting blood sample for assessment of interleukin-6 (IL-6), tumor necrosis factor receptor 1 (TNFR1), C-reactive protein (CRP), leptin, and adiponectin levels. Among non-sleep apneics, females had higher levels of TNFR1 (p = 0.01), CRP (p = 0.005), leptin (p < 0.001), and adiponectin (p < 0.001) compared to males, independent of age and body mass index. When analyzed separately by gender, sleep apneic men had elevated TNFR1 (p = 0.04), CRP (p = 0.06) and IL-6 (p = 0.11) relative to control men; in sleep apneic females, only CRP was elevated (p = 0.04). Furthermore, CRP was associated with apnea severity in a dose-response manner (p-linear = 0.04 in both genders) and was independently associated with comorbid hypertension in apnea (p-linear = 0.005 for women; p-linear = 0.09 for men). In conclusion, although women have naturally higher levels of inflammatory and metabolic markers than men, sleep apneic men appear to have a more severe inflammatory profile compared to women. Our findings suggest that these markers should be analyzed and interpreted separately in men and women, and that a single measure of plasma CRP appears to be a clinically-useful marker of apnea severity and comorbid cardiovascular morbidity.
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Introduction
Obstructive sleep apnea is a prevalent sleep disorder characterized by obstruction of the upper airway during sleep despite breathing effort, as well as an associated reduction in blood oxygen saturation. Seventeen to 24% of men and 5-9% of women in general population samples demonstrate an apnea-hypopnea index (AHI) of five or more events per hour of sleep, while 4% of men and 2% of women meet the current clinical and polysomnographic criteria for the diagnosis of sleep apnea warranting immediate therapeutic intervention (Bixler et al., 1998 (Bixler et al., , 2001 Young et al., 1993) . Sleep apnea has been associated with the elevation of several proinflammatory cytokines, independent of obesity (Kritikou et al., 2014; Sahlman et al., 2010; Shamsuzzaman et al., 2002; Vgontzas et al., 1997 Vgontzas et al., , 2000 Vgontzas et al., , 2008 Among a number of inflammatory pathways, sleep apnea has been especially linked to activation of tumor necrosis factor (TNF)-a receptors, which stimulates secretion of interleukin (IL)-6, in turn triggering the synthesis of C-reactive protein (CRP) in the liver (Akira et al., 1990; Hirano et al., 1990) . It is hypothesized that this inflammatory cascade, in addition to insulin resistance, mediates the link between sleep apnea and cardiometabolic complications (Vgontzas et al., 2005a) .
Although sleep apnea was traditionally recognized in middleaged, obese men, its occurrence in women as well as lean individuals is increasingly recognized. The prevalence of sleep apnea increases markedly after menopause, with post-menopausal women having a doubled rate of apnea compared to pre-menopausal women, even after accounting for neck circumference and body mass index (Bixler et al., 2001; Dancey et al., 2001) . Also, while the maximum prevalence for obstructive sleep apnea peaks between ages 50 and 59 in men (Bixler et al., 1998) , this peak is not seen in females until after age 65 (Bixler et al., 2001) . Furthermore, men tend to have a higher AHI than women when matched for body mass index (Kapsimalis and Kryger, 2002) , are more likely to exhibit the classical symptoms of excessive daytime sleepiness
